ARPA-H Showcases Biosensors and Wearables at INVEST Digital Health Conference
The Advanced Research Projects Agency for Health (ARPA-H) recently showcased innovative biosensors and wearable technologies at the INVEST Digital Health conference in Dallas. ARPA-H, a federal organization, funds research across broad, disease-agnostic focus areas to foster next-generation innovation in healthcare. Among the companies featured were NIRSense, which is developing biosensors to enable the treatment of advanced disease states at home, and Sibel Health, which has created flexible, wireless, wearable vital sign monitors. NIRSense's Chief Commercial Officer, Dan Rodenhaver, highlighted advances in optical sensing technology that can collect data previously requiring blood tests. Sibel Health's Director of Customer Success and Clinical Implementation, Beth Schreiber, explained how their pulse oximeter and chest monitor capture vital sign information to identify early signs of patient deterioration.
